Glycoscience is definitely becoming the most fascinating and important channels of life sciences R&D. It will be critical to development of future biopharmaceuticals, and follow on biologics and biogenerics. (Click here for an article on some research going on in Ireland).
One of the speakers at IFPAC (whose speech will be accessible next week) works right at the crossroads of medicine and the "mechanistic understanding" that Dr. Woodcock spoke of as being the key to resolving the nation's drug development woes. For a breezy and nontechnical profile of MIT professor, Dr. Ram Samisekharen, read on. For a powerpoint of a recent presentation that he made at FDA, click here, and for his web site, click here.
